AyliffeG. A. J., LowburyE. J. I., RoeE.: Transferable Carbenicillin resistance in Pseudomonas aeruginosa. Nature, 235; 141 (1972).
2.
AyliffeG. A. J., BarrywqliffD. F., LowburyE. J. L.: Contamination of disinfectants. Brit. Med. J., 1; 505 (1969).
3.
AndersonK.: The contamination of hexachlorophene soap with Pseudomonas pyocvanea. Med. J. Aust., 2; 463 (1972).
4.
BertaggiaA., NegriM.: Sensibilità in vitro ad antibiotici e chemioterapici di vari ceppi ospedalieri di Pseudomonas Aeruginosa. Boll. Ist. Sieroter. Milanese, 50; 1 (1971).
5.
BollettiM: Le infezioni da Piocianeo. Giorn Mal. Infet. Parassit., 25; 5 (1973).
6.
BollettiM., BenedettiS., De NegriM.: Il trattamento autovaccinico delle meningiti da Piocianeo. Giorn. Mal. Infet. Parassit., 24; 358 (1972).
7.
BollettiM., BertaggiaA.: Prognosi e terapia delle infezioni da Piocianeo. Giorn. Mal. Infet. Parassit., 25; 5 (1973).
8.
BlairJ. E., LenetteE. H., TruantJ. P.: Manual of clinical microbiology. Am. Soc. Microb., 175 (1970).
9.
BassiniA.: Farmaci e rene. Med. int., 31; (1973).
10.
BurdonD. W., WhitbyJ. L.: Contamination of hospital disinfectants with Pseudomonas Species. Brit. Med. J., 2; 153 (1967)
11.
BrumfittW., PercivalA., LeighD. A.: Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet, 1; 1289 (1967).
12.
ChawickP.: Effects of Carbenicillin on Pseudomonas Aeruginosa Can. Med. Ass. J., 401; 410 (1969).
13.
CooperR. G., RiceJ. C., PenfoldJ. L.: Pseudomonas infections treated with carbenicillin and gentamicin. Med. J. Aust.1; 517 (1969).
14.
DaletF.: Efectos de los quimioteràpicos sobre las pseudomonas. Ann. Fund. Puigvert, 2; 37 (1972).
15.
De NegriM.: Eziopatogenesi delle infezioni da Ps. aeruginosa o Piocianeo. Giorn Mal. Infet. Parassit., 25; 5 (1973).
16.
De RosaF., Di NardoV., LottiT.: Contributo allo studio della terapia di infezioni urinarie da Gram-negativi con carbenicillina. Clin Ter., 55; 339–343 (1970).
17.
FominaI. P., KuznetsovaS. M., NavashinS. M.: Sensitivity of clinical strains of Pseudomonas aeruginosa to aminoglicosides, Carbenicillin and their combinations. Atti del 5o Congr. Intern. Mal. Infett. Parassit., Vienna 1970.
GingellJ. C., WaterworthP. M.: Dose of Gentamicin in patients with normal renal function and renal impairment. Brit. Med. J., 9; 19 (1968).
20.
KlasterkyJ., BeumerJ., DaneauD.: Susceptibility of Pseudomonas aeruginosa to combinations of antibiotics. Path. Biol., 20; 15–18, 643–647 (1972).
21.
KlasterkyJ., VamecqG., CappelR.: Effects of the combination of Gentamicin and Carbenicillim on the bactericidal activity of serum. J. Infec. Dis., 152; 2 (1972).
22.
International Symposium of Gentamicin. J. Infect. Dis., 119; 341–540 (1969).
23.
JannuzziC., TassaraA.: Evoluzione della terapia nelle infezioni da Pseudomonas aeruginosa. Giorn. Mal. Infet. Parass., 23; 1051 (1971).
24.
LowburyE. J. L., KidsonA., LillyA.: Sensitivity of Pseudomonas Aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet, 2; 448 (1969).
25.
LowburyE. J. L., BabbJ. R., RoeE.: Clearance from a hospital of Gram-negative bacilli that transfer carbenicillin resistance to Pseudomonas Aeruginosa. Lancet, 4; 941 (1972).
26.
LyonsR. W., ThorntonG. F., AndrioleV. T.: Carbenicillin: clinical and laboratory studies. Infect. Dis., 122; 104 (1970).
27.
MalfattiS., PardiniC., SilviG.: Esperienze cliniche di terapia con carbenicillina in infezioni da Pseudomonas aeruginosa. Giorn. Mal. Infet Parassit., 23; 1063 (1971).
28.
McHenryM. C., GavanT. L., GiffordR. W..: Gentamicin dosages for renal insufficiency. Ann. Int. Med., 74; 192 (1971).
29.
McLaughlinJ. E., ReevesD. S.: Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet, 1; 261 (1971).
MoutonR. P., HoltrigterB.: Carbenicillin and gentamicin in antibiotic combinations in vitro. Chemoter, 14; 371 (1969).
33.
PaganoF., AnselmoG.: Le infezioni da Piocianeo in Urologia. Giorn. Mal. Infet. Parassit., 25; 5 (1973).
34.
PhillipsI., EykynS., LakerM.: Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet, 10; 1258 (1972).
35.
RottiniG.: Sugli aspetti attuali delle infezioni da Pseudomonas aeruginosa.Ed. Minerva Med., Torino1967.
36.
RottiniG.: Le infezioni da Pseudomonas. Giorn. Mal. Infet. Parassit., 20; 855 (1968).
37.
Second International Symposium on Gentamicin. An aminoglycoside antibiotic, Los Angeles, January 25–26, 1971, in J. Infect. Dis., 124; 6–297 (1971).
38.
ShooterR. A..: Food and medicaments as possible sources hospital strains of Pseudomonas aeruginosa. Lancet, 1; 1227 (1969).
39.
SmithC. B., FinlandF.: Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl. Microbiol., 16; 1753–1760 (1968).
40.
SmithC. B., DansP. E., WilfertI. N.: Use of gentamicin with other antibiotics. J. Infect. Dis., 119; 370 (1969).
41.
SmithC. B., WilfertJ. N., DansP. E.: In vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin. J. Infect. Dis., 122; 3–14 (1970).
42.
SonneM., JawetzE.: Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl. Microbiol., 17; 893 (1969).
43.
Symposium on Carbenicillin: A clinical profile January 24, 1970, in J. Infect. Dis., 121; 1–116 (1970).
44.
YuceK., Von RoyemC. E.: Carbenicillin and Gentamicin in the treatment of Pseudomonas aeruginosa inaction. Can. Med. Ass. J., 105; 919 (1971).
